Friday, July 12, 2013

GlaxoSmithKline executives face China bribery probe


Some senior executives of the Chinese division of GlaxoSmithKline (GSK) are facing a criminal investigation.

They are being investigated for bribery and tax related violations, the state owned Xinhua news agency reported.

They are suspected of offering bribes to officials and doctors in an attempt to boost sales in the country.

See full Article: http://www.bbc.co.uk/news/business-23265958